| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRSL.2012.01.005 |
| P8608 | Fatcat ID | release_gb5osaohwbcg7drjsf4mabf3eu |
| P698 | PubMed publication ID | 22683369 |
| P5875 | ResearchGate publication ID | 225286413 |
| P50 | author | David C Zawieja | Q47419069 |
| P2093 | author name string | Mohammad N Uddin | |
| Thomas J Kuehl | |||
| Richard O Jones | |||
| Steven R Allen | |||
| P2860 | cites work | The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia | Q24795491 |
| Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth | Q36817975 | ||
| Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension | Q36974139 | ||
| Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia | Q37119326 | ||
| AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia | Q37132801 | ||
| Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling | Q37217986 | ||
| Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats | Q37449693 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Neurologic complications of pre-eclampsia | Q37493270 | ||
| Emerging role of the bufadienolides in cardiovascular and kidney diseases | Q37736752 | ||
| The concept of the natriuretic hormone and its relation to hypertension. | Q39824388 | ||
| Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function | Q39988758 | ||
| Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells | Q40012513 | ||
| The role of excessive volume expansion in the pathogenesis of preeclampsia | Q40310697 | ||
| Marinobufagenin impairs first trimester cytotrophoblast differentiation | Q40320679 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Pregnancy-related mortality in the United States, 1987-1990. | Q41022994 | ||
| Preeclampsia: an endothelial cell disorder | Q41281924 | ||
| Sodium excretion in normal and hypertensive pregnancy: a prospective study | Q41976105 | ||
| Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women | Q42436216 | ||
| Contribution of angiogenic factors in a rat model of pre-eclampsia | Q42933447 | ||
| Marinobufagenin, resibufogenin and preeclampsia | Q43157537 | ||
| Alterations in the renin-angiotensin system in a rat model of human preeclampsia | Q43218182 | ||
| The treatment of preeclampsia in a rat model employing Digibind | Q43262762 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Genetic variation in solute carrier genes is associated with preeclampsia. | Q44474766 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Gadd45a stress signaling regulates sFlt-1 expression in preeclampsia. | Q46006231 | ||
| A rat model of preeclampsia | Q46342948 | ||
| The prevention and management of pre-eclampsia and eclampsia | Q46357691 | ||
| Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group | Q46362359 | ||
| Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells | Q46668484 | ||
| Involvement of marinobufagenin in a rat model of human preeclampsia | Q46716993 | ||
| Effects of an endogenous ouabainlike compound on heart and aorta | Q46844124 | ||
| Pregnancy prevents hypertensive remodeling of cerebral arteries: a potential role in the development of eclampsia | Q46870281 | ||
| Neurological complications associated with the pre-eclampsia/eclampsia syndrome | Q46890619 | ||
| Resibufogenin corrects hypertension in a rat model of human preeclampsia | Q46919214 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states | Q47771935 | ||
| Endogenous marinobufagenin-like factor in acute plasma volume expansion | Q47771986 | ||
| Extracellular fluid volumes in pregnancy-induced hypertension | Q50798261 | ||
| Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia | Q53300122 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. | Q54230092 | ||
| Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. | Q54426625 | ||
| The upregulation of angiotensin II receptor AT1 in human preeclamptic placenta | Q58029863 | ||
| A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension | Q59079199 | ||
| Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia | Q59367832 | ||
| Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs | Q62633259 | ||
| Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy | Q67321033 | ||
| Measurement of individual plasma angiotensins in normal pregnancy and pregnancy-induced hypertension | Q67947877 | ||
| Renin-aldosterone relationships in pregnancy-induced hypertension | Q68044331 | ||
| Increased fetoplacental active renin production in pregnancy-induced hypertension | Q68178270 | ||
| Analysis of changes in the renin-angiotensin system during pregnancy | Q68640705 | ||
| Hormone production during pregnancy in the primigravid patient. II. Plasma levels of deoxycorticosterone throughout pregnancy of normal women and women who developed pregnancy-induced hypertension | Q71386510 | ||
| Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy | Q71413387 | ||
| Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin | Q71861419 | ||
| Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast | Q72297496 | ||
| Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats | Q72710474 | ||
| Alpha 1-adrenergic receptor antibodies in patients with primary hypertension | Q73089177 | ||
| Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy | Q73141222 | ||
| Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia | Q73154748 | ||
| Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia | Q73305965 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells | Q74188076 | ||
| Preeclampsia -- searching for the cause | Q75425657 | ||
| Human spiral artery renin-angiotensin system | Q77418886 | ||
| Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia | Q77660104 | ||
| Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries | Q77788611 | ||
| The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy | Q78039553 | ||
| The renal excretion of sodium in women with preeclampsia | Q78321878 | ||
| Pressor response to angiotonin in pregnant and nonpregnant women | Q78762451 | ||
| Angiogenic factors and preeclampsia | Q79382870 | ||
| Apoptotic signaling induces hyperpermeability following hemorrhagic shock | Q79793823 | ||
| [Edema in pregnancy--trivial?] | Q81160035 | ||
| Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression | Q81411178 | ||
| Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia | Q82975843 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| Is inflammation the cause of pre-eclampsia? | Q27007059 | ||
| Implantation and the survival of early pregnancy | Q28215729 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Cerebrovascular function in pregnancy and eclampsia | Q28305037 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Blood-brain barrier, brain metabolism and cerebral blood flow | Q30752573 | ||
| Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats | Q32071317 | ||
| Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. | Q33268023 | ||
| Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor | Q33538256 | ||
| Vascular leak in a rat model of preeclampsia | Q33651001 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Current topic: the uteroplacental renin-angiotensin system | Q34001273 | ||
| Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis | Q34170867 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets | Q34605877 | ||
| Endogenous cardiac glycosides, a new class of steroid hormones | Q34655320 | ||
| Pregnancy and the risk of stroke | Q34683028 | ||
| Pre-eclampsia: more than pregnancy-induced hypertension | Q34726951 | ||
| Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia | Q34785813 | ||
| Preeclampsia. Part 1: clinical and pathophysiologic considerations | Q34827918 | ||
| Preeclampsia. Part 2: experimental and genetic considerations | Q34827936 | ||
| Role of Reactive Oxygen Species During Hypertension in Response to Chronic Antiangiogenic Factor (sFlt-1) Excess in Pregnant Rats | Q35086662 | ||
| Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. | Q35172646 | ||
| PLASMA VOLUME, TOTAL CIRCULATING PROTEIN, AND "AVAILABLE FLUID" ABNORMALITIES IN PREECLAMPSIA AND ECLAMPSIA. | Q35389030 | ||
| IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | Q35581520 | ||
| Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Renin angiotensin signaling in normal pregnancy and preeclampsia | Q35743816 | ||
| Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface | Q35889634 | ||
| Role of the renin-angiotensin system in the pathogenesis of preeclampsia | Q36064478 | ||
| Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer | Q36247906 | ||
| Signaling via beta(2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. | Q36404687 | ||
| P433 | issue | 2 | |
| P921 | main subject | pathogenesis | Q372016 |
| biomarker | Q864574 | ||
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 99-113 | |
| P577 | publication date | 2012-02-02 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome | |
| P478 | volume | 160 |
| Q33963982 | A synthetic thiourea-based tripodal receptor that impairs the function of human first trimester cytotrophoblast cells |
| Q37000033 | Apoptotic and stress signaling markers are augmented in preeclamptic placenta and umbilical cord |
| Q35383992 | Endogenous digitalis-like factors: an overview of the history |
| Q37612429 | Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death |
| Q38888539 | Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells. |
| Q49917325 | Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells. |
| Q52723876 | Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling-mediated mitochondrial apoptotic pathway. |
| Q33430391 | Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia |
| Q37199922 | Pathogenesis and promising non-invasive markers for preeclampsia |
| Q33419126 | Pre-eclampsia has an adverse impact on maternal and fetal health |
| Q33748770 | Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells |
Search more.